Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Feb 10, 2025 · CIK: 1725430
Sentiment: neutral
Topics: financial-condition, regulation-fd, exhibits
TL;DR
IBSI filed an 8-K on Feb 10, 2025, covering financials and operations.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on February 10, 2025, reporting on its results of operations and financial condition. The filing also includes information related to Regulation FD disclosure and financial statements and exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and has its principal business address in New York.
Why It Matters
This 8-K filing provides an update on the company's financial performance and operational status, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing providing standard corporate information and financial updates, not indicating any immediate or significant risks.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- February 10, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Intelligent Bio Solutions Inc., along with Regulation FD Disclosure and Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on February 10, 2025.
What were Intelligent Bio Solutions Inc.'s previous names?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
In which state is Intelligent Bio Solutions Inc. incorporated?
Intelligent Bio Solutions Inc. is incorporated in Delaware.
What is the principal business address of Intelligent Bio Solutions Inc.?
The principal business address of Intelligent Bio Solutions Inc. is 135 West 41st Street, 5th Floor, New York, NY 10036.
Filing Stats: 652 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2025-02-10 17:15:11
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 32KB
- ex99-1_001.jpg (GRAPHIC) — 32KB
- ex99-1_002.jpg (GRAPHIC) — 30KB
- ex99-1_003.jpg (GRAPHIC) — 22KB
- ex99-1_004.jpg (GRAPHIC) — 30KB
- ex99-1_005.jpg (GRAPHIC) — 29KB
- ex99-1_006.jpg (GRAPHIC) — 29KB
- 0001493152-25-005677.txt ( ) — 487KB
- inbs-20250210.xsd (EX-101.SCH) — 3KB
- inbs-20250210_lab.xml (EX-101.LAB) — 33KB
- inbs-20250210_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On February 10, 2025, Intelligent Bio Solutions Inc. (the "Company") released a letter to shareholders in the form of press release (the "Press Release") that detailed the Company's 2024 growth and 2025 U.S. expansion strategy. A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing disclosure is qualified in its entirety by the full text of the Press Release. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purpose of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference. Item 9.01 Financial Statements and Exhibits. No. Description 99.1 Press release dated February 10, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 10, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer